Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Pozycja w akcjach #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Cena akcji
$0.49606484
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$88.47M
Zmiana (1 dzień)
-1.58%
Zmiana (1 rok)
-22.51%
Kraj
TW
Handel Intech Biopharm Corporation (6461)

Kategoria

Historia ceny akcji dla Intech Biopharm Corporation (6461)
Najwyższa cena zamknięcia: $0.51 dnia 2026-08-01

Najniższa cena zamknięcia: $2.53 dnia 2014-07-01
Historia cen akcji firmy Intech Biopharm Corporation od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 14.95%
2025 -41.62%
2024 -9.11%
2023 -16.45%
2022 54.36%
2021 -3.00%
2020 22.52%
2019 -6.95%
2018 -49.08%
2017 20.07%
2016 -28.29%
2015 0.41%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH